ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Effects of Telomere Related Senescence-Genes in Cervical Cancer.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Globally, cervical cancer is a prevalent cancer among women and ranks as the fourth leading cause of mortality in gynecological cancers. However, how telomeres affect cervical cancer remains uncertain. The research entailed the procurement of telomere-associated genes (TRGs) from TelNet. The Cancer Genome Atlas (TCGA) database provided the clinical data and TRG expression rates in patients with cervical cancer. Within the TCGA-CESC dataset, 327 TRGs were identified, differentiating between cancerous and healthy tissues. Subsequently, we combined genes linked to aging and telomeres, leading to 31 overlapping genes and performing an analysis of functional enrichment on these essential genes. Genes unique to telomeres and closely associated with cervical cancer play various roles, mainly in the cell cycle, DNA replication, and DNA repair processes. Key genes, such as those associated with cell aging, homologous recombination, and Human T-cellleukemia virus 1 infection, are vital in the life cycle of a cell. Dysfunction in these genes could lead to irregularities in cellular synthesis and apoptosis processes, potentially accelerating the progression of cervical cancer. Subsequently, the data was analyzed sequentially using single-factor Cox regression, Lasso regression, and multi-factor Cox regression techniques, leading to the development of the TRGs risk model.Among the pinpointed TCGA group (p < 0.001), cervical cancer sufferers with high-risk TRGs showed poorer outcomes. Furthermore, the TRGs risk score emerged as an independent risk factor for cervical cancer. Additionally, communities susceptible to TRGs could benefit from specific medical interventions. To conclude, our team developed a genetic risk model associated with telomeres to predict outcomes in cervical cancer patients, potentially assisting in selecting suitable treatment drugs for them.
Indexed as
Identifiers
42855652What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.